MorphoSys AG
XETRA:MOR
MorphoSys AG
Tax Provision
MorphoSys AG
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MorphoSys AG
XETRA:MOR
|
Tax Provision
€2.8m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Tax Provision
-€255.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-203%
|
CAGR 10-Years
N/A
|
|
CureVac NV
NASDAQ:CVAC
|
Tax Provision
-€198k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
Tax Provision
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Tax Provision
€20.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Formycon AG
XETRA:FYB
|
Tax Provision
-€3.3m
|
CAGR 3-Years
-238%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is MorphoSys AG's Tax Provision?
Tax Provision
2.8m
EUR
Based on the financial report for Mar 31, 2024, MorphoSys AG's Tax Provision amounts to 2.8m EUR.
What is MorphoSys AG's Tax Provision growth rate?
Tax Provision CAGR 5Y
-7%
The average annual Tax Provision growth rates for MorphoSys AG have been -66% over the past three years , -7% over the past five years .